nr |
titel |
type |
1 |
Journal of the American Pharmaceutical Association, vol. 36, no. 1 (1996)
|
aflevering |
2 |
Journal of the American Pharmaceutical Association, vol. 38, no. 1 (1998)
|
aflevering |
3 |
Journal of the American Pharmaceutical Association, vol. 37, no. 1 (1997)
|
aflevering |
4 |
Journal of the American Pharmaceutical Association, vol. 41, no. 1 (2001)
|
aflevering |
5 |
Journal of the American Pharmaceutical Association, vol. 43, no. 1 (2003)
|
aflevering |
6 |
Journal of the American Pharmaceutical Association, vol. 39, no. 1 (1999)
|
aflevering |
7 |
Journal of the American Pharmaceutical Association, vol. 42, no. 1 (2002)
|
aflevering |
8 |
Journal of the American Pharmaceutical Association, vol. 40, no. 1 (2000)
|
aflevering |
9 |
Journal of the American Pharmaceutical Association, vol. 36, no. 10 (1996)
|
aflevering |
10 |
Journal of the American Pharmaceutical Association, vol. 36, no. 11 (1996)
|
aflevering |
11 |
Journal of the American Pharmaceutical Association, vol. 36, no. 12 (1996)
|
aflevering |
12 |
Journal of the American Pharmaceutical Association, vol. 41, no. 1S (2001)
|
aflevering |
13 |
Journal of the American Pharmaceutical Association, vol. 39, no. 1S (1999)
|
aflevering |
14 |
Journal of the American Pharmaceutical Association, vol. 40, no. 1S (2000)
|
aflevering |
15 |
Journal of the American Pharmaceutical Association, vol. 36, no. 2 (1996)
|
aflevering |
16 |
Journal of the American Pharmaceutical Association, vol. 40, no. 2 (2000)
|
aflevering |
17 |
Journal of the American Pharmaceutical Association, vol. 42, no. 2 (2002)
|
aflevering |
18 |
Journal of the American Pharmaceutical Association, vol. 43, no. 2 (2003)
|
aflevering |
19 |
Journal of the American Pharmaceutical Association, vol. 37, no. 2 (1997)
|
aflevering |
20 |
Journal of the American Pharmaceutical Association, vol. 39, no. 2 (1999)
|
aflevering |
21 |
Journal of the American Pharmaceutical Association, vol. 38, no. 2 (1998)
|
aflevering |
22 |
Journal of the American Pharmaceutical Association, vol. 41, no. 2 (2001)
|
aflevering |
23 |
Journal of the American Pharmaceutical Association, vol. 40, no. 2S (2000)
|
aflevering |
24 |
Journal of the American Pharmaceutical Association, vol. 41, no. 2S (2001)
|
aflevering |
25 |
Journal of the American Pharmaceutical Association, vol. 39, no. 2S (1999)
|
aflevering |
26 |
Journal of the American Pharmaceutical Association, vol. 37, no. 3 (1997)
|
aflevering |
27 |
Journal of the American Pharmaceutical Association, vol. 39, no. 3 (1999)
|
aflevering |
28 |
Journal of the American Pharmaceutical Association, vol. 36, no. 3 (1996)
|
aflevering |
29 |
Journal of the American Pharmaceutical Association, vol. 40, no. 3 (2000)
|
aflevering |
30 |
Journal of the American Pharmaceutical Association, vol. 41, no. 3 (2001)
|
aflevering |
31 |
Journal of the American Pharmaceutical Association, vol. 38, no. 3 (1998)
|
aflevering |
32 |
Journal of the American Pharmaceutical Association, vol. 42, no. 3 (2002)
|
aflevering |
33 |
Journal of the American Pharmaceutical Association, vol. 36, no. 4 (1996)
|
aflevering |
34 |
Journal of the American Pharmaceutical Association, vol. 38, no. 4 (1998)
|
aflevering |
35 |
Journal of the American Pharmaceutical Association, vol. 37, no. 4 (1997)
|
aflevering |
36 |
Journal of the American Pharmaceutical Association, vol. 39, no. 4 (1999)
|
aflevering |
37 |
Journal of the American Pharmaceutical Association, vol. 42, no. 4 (2002)
|
aflevering |
38 |
Journal of the American Pharmaceutical Association, vol. 41, no. 4 (2001)
|
aflevering |
39 |
Journal of the American Pharmaceutical Association, vol. 40, no. 4 (2000)
|
aflevering |
40 |
Journal of the American Pharmaceutical Association, vol. 37, no. 5 (1997)
|
aflevering |
41 |
Journal of the American Pharmaceutical Association, vol. 39, no. 5 (1999)
|
aflevering |
42 |
Journal of the American Pharmaceutical Association, vol. 36, no. 5 (1996)
|
aflevering |
43 |
Journal of the American Pharmaceutical Association, vol. 42, no. 5 (2002)
|
aflevering |
44 |
Journal of the American Pharmaceutical Association, vol. 38, no. 5 (1998)
|
aflevering |
45 |
Journal of the American Pharmaceutical Association, vol. 40, no. 5 (2000)
|
aflevering |
46 |
Journal of the American Pharmaceutical Association, vol. 41, no. 5 (2001)
|
aflevering |
47 |
Journal of the American Pharmaceutical Association, vol. 39, no. 5S (1999)
|
aflevering |
48 |
Journal of the American Pharmaceutical Association, vol. 41, no. 5S1 (2001)
|
aflevering |
49 |
Journal of the American Pharmaceutical Association, vol. 42, no. 5S1 (2002)
|
aflevering |
50 |
Journal of the American Pharmaceutical Association, vol. 40, no. 5S1 (2000)
|
aflevering |
51 |
Journal of the American Pharmaceutical Association, vol. 41, no. 5S2 (2001)
|
aflevering |
52 |
Journal of the American Pharmaceutical Association, vol. 36, no. 6 (1996)
|
aflevering |
53 |
Journal of the American Pharmaceutical Association, vol. 37, no. 6 (1997)
|
aflevering |
54 |
Journal of the American Pharmaceutical Association, vol. 41, no. 6 (2001)
|
aflevering |
55 |
Journal of the American Pharmaceutical Association, vol. 42, no. 6 (2002)
|
aflevering |
56 |
Journal of the American Pharmaceutical Association, vol. 40, no. 6 (2000)
|
aflevering |
57 |
Journal of the American Pharmaceutical Association, vol. 39, no. 6 (1999)
|
aflevering |
58 |
Journal of the American Pharmaceutical Association, vol. 38, no. 6 (1998)
|
aflevering |
59 |
Journal of the American Pharmaceutical Association, vol. 39, no. 6S (1999)
|
aflevering |
60 |
Journal of the American Pharmaceutical Association, vol. 40, no. 6S (2000)
|
aflevering |
61 |
Journal of the American Pharmaceutical Association, vol. 41, no. 6S1 (2001)
|
aflevering |
62 |
Journal of the American Pharmaceutical Association, vol. 42, no. 6S2 (2002)
|
aflevering |
63 |
Journal of the American Pharmaceutical Association, vol. 36, no. 7 (1996)
|
aflevering |
64 |
Journal of the American Pharmaceutical Association, vol. 36, no. 8 (1996)
|
aflevering |
65 |
Journal of the American Pharmaceutical Association, vol. 36, no. 9 (1996)
|
aflevering |
66 |
Journal of the American Pharmaceutical Association, vol. 40, no. S1 (2000)
|
aflevering |
67 |
Journal of the American Pharmaceutical Association, vol. 41, no. S1 (2001)
|
aflevering |
68 |
Journal of the American Pharmaceutical Association, vol. 39, no. S1 (1999)
|
aflevering |
69 |
Journal of the American Pharmaceutical Association, vol. 40, no. S2 (2000)
|
aflevering |
70 |
Journal of the American Pharmaceutical Association, vol. 39, no. S2 (1999)
|
aflevering |
71 |
Journal of the American Pharmaceutical Association, vol. 41, no. S2 (2001)
|
aflevering |
72 |
Journal of the American Pharmaceutical Association, vol. 41, no. S3 (2001)
|
aflevering |
73 |
Journal of the American Pharmaceutical Association, vol. 41, no. S4 (2001)
|
aflevering |
74 |
Journal of the American Pharmaceutical Association, vol. 41, no. S5 (2001)
|
aflevering |
75 |
Journal of the American Pharmaceutical Association, vol. 39, no. S5 (1999)
|
aflevering |
76 |
Journal of the American Pharmaceutical Association, vol. 40, no. S6 (2000)
|
aflevering |
77 |
Journal of the American Pharmaceutical Association, vol. 39, no. S6 (1999)
|
aflevering |
78 |
Journal of the American Pharmaceutical Association, vol. 41, no. S6 (2001)
|
aflevering |